Syndax Pharmaceuticals · 23 hours ago
Associate Director, Early Development - Program Management
Maximize your interview chances
BiotechnologyClinical Trials
Insider Connection @Syndax Pharmaceuticals
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Drive program and project management for drug discovery and pre-clinical development phases, ensuring alignment with strategic goals and timelines. Build and facilitate internal cross-functional core teams.
Schedule and facilitate meetings, prepare agendas and meeting minutes, track action items, manage team dynamics, and escalate risks as appropriate, to ensure execution of research plans.
Provide expert program management support and guidance on early development processes, from target identification through to IND filing.
Coordinate and participate in meetings with both internal and external partners, working with them to develop and foster productive cross-company relationships; assist with governance meetings and other activities.
Develop and manage detailed project plans, timelines, and budgets to achieve key milestones and deliverables.
Identify potential risks and develop mitigation strategies to ensure program success.
Maintain clear and effective communication with internal and external stakeholders, providing regular updates on program status and progress. Work with Project Leader on program objectives and priorities, scenario planning, governance presentations.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
BA/BS in a relevant science field
Minimum 5 years of experience in Program Management or an adjacent role in biotech
Overall experience in the industry 7+ years
Significant experience in early drug discovery (e.g., target identification, hit to-lead stages) and late drug discovery (e.g., candidate stage, preclinical/IND enabling stages) in the capacity as a program/project manager
Prior experience managing or working within cross-functional project teams with timeline management and budgetary responsibility on early-stage drug development programs
Strong experience working with external partners, including contract labs, CROs, CDMOs, and others to ensure clear project scope, timelines, deliverables, and oversight
Early Development Expertise: Knowledge of early drug development including the transition of novel candidates from discovery through first in man studies
Project Management Experience: Extensive experience in project management, with a strong understanding of project management principles and methodologies
Strong analytical and problem-solving abilities to address technical issues and improve tool functionality
Strong verbal and written communication skills to effectively listen to, collaborate with, and design new solutions with team members and stakeholders
Ability to thrive in a fast-paced environment; ability to adapt to changes with demonstrated flexibility to pivot fearlessly as warranted and needed
Strong interpersonal skills and the ability to work collaboratively with cross-functional teams
Proactive and self-motivated with a strong sense of responsibility
Ability to work independently and as part of a team
Strong problem-solving skills and the ability to think critically
Preferred
Graduate degree highly preferred
Formal Project Management Training or Certification (e.g., PMP, PRINCE2) is highly preferred
Laboratory experience in an academic, pharmaceutical or biotechnology setting including contributions to IND-enabling work
Technical Proficiency: Strong knowledge of project management tools and software; Smartsheet experience is preferred
Company
Syndax Pharmaceuticals
Syndax Pharmaceuticals focuses on developing an HDAC inhibitor for solid tumors and hematological tumors.
Funding
Current Stage
Public CompanyTotal Funding
$803.58M2023-12-14Post Ipo Equity· $230M
2022-12-06Post Ipo Equity· $150M
2021-12-15Post Ipo Equity· $75.3M
Leadership Team
Recent News
2024-11-27
GlobeNewswire News Room
2024-11-21
Company data provided by crunchbase